Strategic Joint Ventures
Co-Diagnostics announced joint ventures with CoSara in India and CoMira in Saudi Arabia. The CoSara SPAC transaction is expected to unlock significant value, while CoMira marks expansion into 19 MENA countries, strengthening the company's international footprint.
AI Business Unit Launch
The launch of an AI business unit led by the Co-Dx Primer AI platform aims to enhance diagnostics, improve operational efficiency, and provide predictive epidemiological insights.
Upper Respiratory Multiplex Test
Initiation of clinical evaluations for a comprehensive respiratory panel detecting flu A, flu B, COVID-19, and RSV, supported by a RADx Tech grant from the NIH.
Improved Financial Efficiency
Operating expenses decreased from $10.6 million in Q3 2024 to $7.1 million in Q3 2025, reflecting operational efficiency improvements.